title: Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity.
abstract: The aim of this work was to investigate doxorubicin (DOX) percutaneous absorption and retention in the skin following iontophoresis. The convective flow contribution to the overall electrotransport of DOX was also elucidated for a non-ionic hydroxyethylcellulose gel and a cationic chitosan gel. Moreover, the cytotoxicity of DOX and its formulations, with and without low electrical current, was verified. It was observed that iontophoresis of DOX significantly increased the skin permeation and retention of the drug. In addition, the electroosmotic flow was dramatically reduced when DOX was added to the non-ionic gel, thereby indicating that the drug interacted with negative charges in the skin. Interestingly, electroosmosis was also significantly reduced when the iontophoresis was performed in the presence of the chitosan gel, but in the absence of DOX. Consequently, the transport of an electroosmotic marker from this gel almost disappeared when the positively charged drug was added to the cationic gel. These results indicated that chitosan appeared to interact with negative charges in the skin. Hence, this carrier not only reduced electroosmotic flow, but also released DOX from ionic interactions with these sites and improved its diffusion to deeper skin layers. The application of the low electrical current directly to melanoma cells increased DOX cytotoxicity by nearly three-fold, which was probably due to membrane permeation.
authors.affiliation: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Av. do Café s/no., 14040-903, Ribeirão Preto, São Paulo, Brazil.
authors.forename: Stephânia F
authors.initials: SF
authors.lastname: Taveira
authors.forename: Auro
authors.initials: A
authors.lastname: Nomizo
authors.forename: Renata F V
authors.initials: RF
authors.lastname: Lopez
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000493:pharmacokinetics* / Q000633:toxicity*; D045744:Cell Line, Tumor; D048271:Chitosan / Q000493:pharmacokinetics / Q000633:toxicity*; D004317:Doxorubicin / Q000493:pharmacokinetics* / Q000633:toxicity*; D053841:Electroosmosis; D007478:Iontophoresis; D051189:Murinae; D012867:Skin / Q000378:metabolism*; D012869:Skin Absorption; D013552:Swine
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; D048271:Chitosan